Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
915.3 DKK | +1.33% | +0.64% | +31.18% |
09:52am | Eli Lilly's diabetes drug tirzepatide gets approval in China | RE |
08:18am | AstraZeneca aims for $80 bln in total revenue by 2030 | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.10% | 583B | |
+34.35% | 705B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.07% | 238B | |
-3.07% | 210B | |
+10.31% | 209B | |
+9.21% | 169B | |
-0.90% | 162B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications